Analyst Ratings For AstraZeneca plc (LON:AZN)
Today, Goldman Sachs Group set its price target on AstraZeneca plc (LON:AZN) to GBX 4,080 per share.
There are 13 Buy Ratings, 7 Hold Ratings, 2 Sell Ratings, 1 Strong Buy Ratings on the stock.
The current consensus rating on AstraZeneca plc (LON:AZN) is Buy with a consensus target price of GBX 5,686.76 per share, a potential .
Some recent analyst ratings include
- 8/31/2018-AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Liberum Capital
- 8/30/2018-AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Shore Capital
- 8/21/2018-AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by JPMorgan Chase & Co. with a GBX 6,500 price target
- 8/20/2018-AstraZeneca plc (LON:AZN) had its top pick rating reiterated by Barclays
Recent Trading Activity for AstraZeneca plc (LON:AZN)
Shares of AstraZeneca plc closed the previous trading session at 797,00 −113,00 1,91 % with 1528714 shares trading hands.
